8-85177559-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001951.4(E2F5):​c.139G>A​(p.Gly47Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000365 in 1,259,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )

Consequence

E2F5
NM_001951.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.44
Variant links:
Genes affected
E2F5 (HGNC:3119): (E2F transcription factor 5) The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionarily conserved domains that are present in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein is differentially phosphorylated and is expressed in a wide variety of human tissues. It has higher identity to E2F4 than to other family members. Both this protein and E2F4 interact with tumor suppressor proteins p130 and p107, but not with pRB. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.027671844).
BS2
High AC in GnomAd4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
E2F5NM_001951.4 linkc.139G>A p.Gly47Ser missense_variant Exon 1 of 8 ENST00000416274.7 NP_001942.2 Q15329-1
E2F5NM_001083588.2 linkc.139G>A p.Gly47Ser missense_variant Exon 1 of 8 NP_001077057.1 Q15329-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
E2F5ENST00000416274.7 linkc.139G>A p.Gly47Ser missense_variant Exon 1 of 8 1 NM_001951.4 ENSP00000398124.2 Q15329-1
E2F5ENST00000418930.6 linkc.139G>A p.Gly47Ser missense_variant Exon 1 of 8 1 ENSP00000414312.2 Q15329-2
ENSG00000254208ENST00000520129.1 linkn.431C>T non_coding_transcript_exon_variant Exon 2 of 2 5
E2F5ENST00000256117.9 linkn.-54G>A upstream_gene_variant 5 ENSP00000256117.6 C9JYE9

Frequencies

GnomAD3 genomes
AF:
0.0000861
AC:
13
AN:
150958
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000593
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000804
AC:
5
AN:
62204
AF XY:
0.0000282
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00124
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000298
AC:
33
AN:
1108628
Hom.:
0
Cov.:
32
AF XY:
0.0000246
AC XY:
13
AN XY:
528562
show subpopulations
Gnomad4 AFR exome
AF:
0.00
AC:
0
AN:
23798
Gnomad4 AMR exome
AF:
0.000383
AC:
5
AN:
13044
Gnomad4 ASJ exome
AF:
0.00107
AC:
15
AN:
13998
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
28192
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
23032
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
26742
Gnomad4 NFE exome
AF:
0.00000965
AC:
9
AN:
933002
Gnomad4 Remaining exome
AF:
0.0000911
AC:
4
AN:
43888
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000861
AC:
13
AN:
150958
Hom.:
0
Cov.:
32
AF XY:
0.0000814
AC XY:
6
AN XY:
73716
show subpopulations
Gnomad4 AFR
AF:
0.00
AC:
0
AN:
0
Gnomad4 AMR
AF:
0.000593
AC:
0.000593198
AN:
0.000593198
Gnomad4 ASJ
AF:
0.000865
AC:
0.000865052
AN:
0.000865052
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000148
AC:
0.000014771
AN:
0.000014771
Gnomad4 OTH
AF:
0.00
AC:
0
AN:
0
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000144
ExAC
AF:
0.0000554
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 29, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.139G>A (p.G47S) alteration is located in exon 1 (coding exon 1) of the E2F5 gene. This alteration results from a G to A substitution at nucleotide position 139, causing the glycine (G) at amino acid position 47 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
23
DANN
Benign
0.94
DEOGEN2
Benign
0.052
.;T
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.55
T;T
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.028
T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.34
N;N
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.50
N;N
REVEL
Benign
0.047
Sift
Benign
0.47
T;T
Sift4G
Benign
0.65
T;T
Polyphen
0.062
B;B
Vest4
0.15
MutPred
0.15
Gain of phosphorylation at G47 (P = 0.0119);Gain of phosphorylation at G47 (P = 0.0119);
MVP
0.20
MPC
1.3
ClinPred
0.074
T
GERP RS
1.6
Varity_R
0.056
gMVP
0.23
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs749449900; hg19: chr8-86089794; API